Ishihara H, Asahi Y, Kuroki M, Saijo K, et al. Prognosis After Discontinued Treatment due to Immune-Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma. Head Neck 2025 Sep 12. doi: 10.1002/hed.70043.
PMID: 40937641